# Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

> **NCT07710781** · NA · NOT_YET_RECRUITING · sponsor: **Ossium Health, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Hematologic Malignancy
- Acute Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Acute Biphenotypic Leukemia
- Acute Undifferentiated Leukemia
- CLL (Chronic Lymphocytic Leukemia)
- Chronic Myeloid Leukemia
- MDS (Myelodysplastic Syndrome)
- Non Hodgkin Lymphoma
- Hodgkin Lymphoma
- Cutaneous T Cell Lymphomas (CTCL)

## Interventions

- **OTHER:** Ossium HPC, Marrow
- **OTHER:** Standard of care living donor - Haplo Related
- **OTHER:** Standard of care living donor - Mismatched Unrelated

## Key facts

- **NCT ID:** NCT07710781
- **Lead sponsor:** Ossium Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2029-03-31
- **Final completion:** 2031-03-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710781, "Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07710781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*